IEEE Trans Biomed Eng. 2022 Aug;69(8):2443-2455. doi: 10.1109/TBME.2022.3147066. Epub 2022 Jul 20.
Tracking changes in hemodynamic congestion and the consequent proactive readjustment of treatment has shown efficacy in reducing hospitalizations for patients with heart failure (HF). However, the cost-prohibitive nature of these invasive sensing systems precludes their usage in the large patient population affected by HF. The objective of this research is to estimate the changes in pulmonary artery mean pressure (PAM) and pulmonary capillary wedge pressure (PCWP) following vasodilator infusion during right heart catheterization (RHC), using changes in simultaneously recorded wearable seismocardiogram (SCG) signals captured with a small wearable patch.
A total of 20 patients with HF (20% women, median age 55 (interquartile range (IQR), 44-64) years, ejection fraction 24 (IQR, 16-43)) were fitted with a wearable sensing patch and underwent RHC with vasodilator challenge. We divided the dataset randomly into a training-testing set (n = 15) and a separate validation set (n = 5). We developed globalized (population) regression models to estimate changes in PAM and PCWP from the changes in simultaneously recorded SCG.
The regression model estimated both pressures with good accuracies: root-mean-square-error (RMSE) of 2.5 mmHg and R of 0.83 for estimating changes in PAM, and RMSE of 1.9 mmHg and R of 0.93 for estimating changes in PCWP for the training-testing set, and RMSE of 2.7 mmHg and R of 0.81 for estimating changes in PAM, and RMSE of 2.9 mmHg and R of 0.95 for estimating changes in PCWP for the validation set respectively.
Changes in wearable SCG signals may be used to track acute changes in intracardiac hemodynamics in patients with HF.
This method holds promise in tracking longitudinal changes in hemodynamic congestion in hemodynamically-guided remote home monitoring and treatment for patients with HF.
通过跟踪血液动力学充血的变化,并相应地主动调整治疗,已经证明可有效降低心力衰竭(HF)患者的住院率。然而,这些有创传感系统的成本过高,使得它们无法在受 HF 影响的大量患者中使用。本研究旨在使用小型可穿戴贴片同时记录的可穿戴地震心动图(SCG)信号变化来估计右心导管检查(RHC)期间血管扩张剂输注后肺动脉平均压(PAM)和肺毛细血管楔压(PCWP)的变化。
共 20 名 HF 患者(20%为女性,中位年龄 55(四分位距(IQR),44-64)岁,射血分数 24(IQR,16-43))佩戴了可穿戴传感器贴片,并接受了 RHC 加血管扩张剂挑战。我们将数据集随机分为训练-测试集(n = 15)和单独的验证集(n = 5)。我们开发了全球化(人群)回归模型,从同时记录的 SCG 变化中估计 PAM 和 PCWP 的变化。
回归模型对两种压力的估计都具有较高的精度:训练-测试集的 PAM 变化 RMSE 为 2.5mmHg,R 为 0.83,PCWP 变化 RMSE 为 1.9mmHg,R 为 0.93,验证集的 PAM 变化 RMSE 为 2.7mmHg,R 为 0.81,PCWP 变化 RMSE 为 2.9mmHg,R 为 0.95。
可穿戴式 SCG 信号的变化可用于跟踪 HF 患者心内血液动力学的急性变化。
该方法有望用于 HF 患者的血液动力学指导远程家庭监测和治疗中,跟踪血液动力学充血的纵向变化。